Phase I trial of a monoclonal antibody specific for α vβ3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion
- Douglas G. McNeel
- , Jens Eickhoff
- , Fred T. Lee
- , David M. King
- , Dona Alberti
- , James P. Thomas
- , Andreas Friedl
- , Jill Kolesar
- , Rebecca Marnocha
- , Jennifer Volkman
- , Jianliang Zhang
- , Luz Hammershaimb
- , James A. Zwiebel
- , George Wilding
Research output: Contribution to journal › Article › peer-review
145
Scopus
citations